Ignite Creation Date:
2024-05-06 @ 2:08 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04224272
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-06
First Post:
2020-01-07
Brief Title:
A Study of ZW25 Zanidatamab With Palbociclib Plus Fulvestrant in Patients With HER2HR Advanced Breast Cancer
Sponsor:
Jazz Pharmaceuticals
Organization:
Jazz Pharmaceuticals
Organization Data
Organization:
Jazz Pharmaceuticals
Class:
INDUSTRY
Study ID:
ZWI-ZW25-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jazz Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None